BriaCell Therapeutics Corp. (BCTX) vs HeartBeam, Inc. (BEAT)

A side-by-side comparison of BriaCell Therapeutics Corp. and HeartBeam, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BriaCell Therapeutics Corp. logo
BCTX
BriaCell Therapeutics Corp.
$36M
$4.18HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
$36M
$0.65HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BCTX vs BEAT

growth of $100 · dividends reinvested · last 5y
BCTX -99.7% (-69.2%/yr)BEAT -86.1% (-32.6%/yr)BEAT compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$0$14
BCTX BEAT

BCTX vs BEAT: by the numbers

  • •BCTX is the larger company ($36M vs $36M market cap).

Metrics side by side

Valuation

MetricBCTXBEAT
P/B ratio1.514.44

Profitability

MetricBCTXBEAT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-154.06%-248.21%
ROIC-164.58%-249.58%

Growth (annualized)

MetricBCTXBEAT
Total return CAGR (5Y)-67.32%N/A

Go deeper

Full BCTX analysisFull BEAT analysisInteractive comparison tool

Dig into the metrics

BriaCell Therapeutics ROEHeartBeam ROEBriaCell Therapeutics operating marginHeartBeam operating marginBriaCell Therapeutics revenue growthHeartBeam revenue growthBriaCell Therapeutics free cash flowHeartBeam free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.